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Abstract 
Background: Thyroid-derived cell models are commonly used to investigate the characteristics of thyroid cancers. It 
is noteworthy that each in vitro single cell model system imitates only a few characteristics of thyroid cancer depend-
ing on e.g. source of cells or oncogene used to transform the cells.
Methods: In the current work we utilized rat thyroid cancer cell models to determine their clinical relevance in redox 
gene studies by comparing in vitro expression data to thyroid Oncomine microarray database. To survey the cell lines 
we analyzed mRNA expression of genes that produce superoxide anion (nox family), genes that catalyze destruction 
of superoxide anion to hydrogen peroxide (sod family), and genes that remove hydrogen peroxide from cellular envi-
ronment (catalase, gpx family and prdx family).
Results: Based on the current results, rat thyroid PC Cl3, PC PTC1, PC E1A, or FRLT5 cell models can be used to study 
NOX2, NOX4, SOD2, SOD3, CATALASE, GPX1, GPX2, GPX5, PRDX2, and PRDX3 gene expression and function.
Conclusions: Redox gene expression in rat originated single cell model systems used to study human thyroid 
carcinogenesis corresponds only partly with human redox gene expression, which may be caused by differences in 
redox gene activation stimulus. The data suggest careful estimation of the data observed in rat thyroid in vitro models.
Keywords: Thyroid cancer, Redox gene expression, Cell line, Cell model, Rat, PC Cl3, FRTL5, SOD3, Extracellular 
superoxide dismutase
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Background
Tumors of thyroid gland, which include e.g. differentiated 
papillary thyroid cancer and poorly differentiated ana-
plastic thyroid cancer, are among the foremost-character-
ized cancers. A number of cell models have been created 
to study signal transduction and function of oncogenes 
in thyroid carcinogenesis [1–4]. These model systems, 
however, may not reflect all aspects of thyroid cancers 
emphasizing the need to compare the gene expression 
between the cell model system and human tissues.
Although the function of reactive oxygen species (ROS) 
is unspecific they are important mediators of tumor for-
mation inducing mutations and regulating signal trans-
duction, thus affecting a large range of cellular molecules. 
Reduction/oxidation (redox) system is highly sensitive to 
cellular changes, such as ageing and transformation, and 
therefore can function as a sensor in cell differentiation 
and carcinogenesis. The importance of ROS for primary 
cell immortalization and transformation was emphasized 
by a study demonstrating that increased nox1 expression 
is essential for cellular transformation by ras oncogene 
[5]. NOX proteins are catalytic subunits in NADPH com-
plexes inducing superoxide anion (O2−) production and 
activating signal transduction by interacting with other 
cellular proteins. Superoxide dismutase (SOD) gene fam-
ily catalyzes dismutation of superoxide anion into hydro-
gen peroxide (H2O2), which is then further metabolized 
by catalase, glutathione peroxidase (GPX) family, and 
peroxiredoxin (PRDX) family.
To characterize thyroid cancer models derived from rat 
primary thyroid cells we analyzed the expression of dif-
ferent nox genes representing superoxide anion radical 
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source and sod, catalase, gpx, and prdx gene families that 
dismutase superoxide to hydrogen peroxide and further 
to less reactive derivatives, such as oxygen and water 
molecules. The obtained expression data was compared 
to microarray data from thyroid cancer patients to vali-
date the use of cell models in redox studies.
Results
Expression of NOX1‑4, SOD1‑3, GPX1‑8, and PRDX1‑6 genes 
in normal human thyroid, papillary thyroid cancer, and in 
anaplastic thyroid cancer
Although ROS are important second messengers in 
normal cellular functions, in pathological conditions, 
such as cancer, redox enzyme expression is unbalanced 
causing oxidative stress. Thyroid carcinogenesis models 
consist of a number of different in vitro models that are 
derived from rat origin by transforming the cells with 
oncogenes. Since rat and human thyroid models may 
have different characteristics, especially in highly sen-
sitive redox system, in the current work we analyzed 
redox gene expression in PC Cl3 and FRLT5 derived 
thyroid cancer models. For the survey we selected 
redox enzymes producing superoxide anion (O2−) 
and on enzymes neutralizing it to hydrogen perox-
ide (H2O2) and further to e.g. water (H2O) and oxygen 
(O2). To compare the observed redox gene expression 
in rat thyroid cell models with human thyroid tissue 
and thyroid cancers we first extracted microarray data 
from Oncomine database (http://www.oncomine.org) 
that contains a number of patients and hence moderate 
the differences observed between individuals. NOX1, 
NOX3, and NOX5 expression suggested minor changes 
in thyroid cancers (Fig. 1a, c, e), whereas the expression 
of NOX2 and NOX4 showed increased mRNA synthe-
sis in papillary thyroid and anaplastic thyroid cancers 
(Fig. 1b, d). SOD1 stayed at similar levels, SOD2 expres-
sion increased in cancer, and SOD3 mRNA synthesis 
decreased correlating to reduced differentiation degree 
of thyroid tissue (Fig.  1f–h). CATALASE expression 
was markedly decreased in anaplastic thyroid cancer as 
compared to normal thyroid tissue and papillary thyroid 
cancer (Fig.  1i). Glutathione peroxidase family showed 
variable gene expression: GPX1 and GPX2 expression 
analysis suggested minor increase in mRNA synthe-
sis (Fig.  1j, k), GPX3, GPX5, and GPX7 expression was 
downregulated in thyroid cancers (Fig. 1l, n, o), whereas 
GPX4 expression did not change (Fig.  1m). PRDX1, 
PRDX2, and PRDX3 mRNA synthesis decreased in pap-
illary and anaplastic thyroid cancers (Fig. 1p–r), PRDX4 
mRNA expression was moderately increased in anaplas-
tic thyroid cancer tissues (Fig.  1s), and PRDX6 expres-
sion status was at similar levels in normal thyroid and 
thyroid cancers (Fig. 1t).
TSH increases redox gene expression in rat FRLT5 cells
Rat thyroid cells immortalized and transformed with 
oncogenes are widely used to study the development of 
thyroid cancer. Previous studies have suggested increased 
ROS production in cells treated with thyroid stimulating 
hormone (TSH) [6, 7], which binds to G-protein couple 
TSH receptor (TSH-R) and activates downstream signal 
cascades, such as cyclic AMP, PKA, PKC, ERK1/2, PI3K-
AKT. Hence, we dissected nox1-4, sod1-3, catalase, gpx1-
8, and prdx1-6 expression status in rat thyroid FRLT5 
stimulated with TSH.
The data shown in Fig. 2 suggested that TSH stimula-
tion of cells after three-day hormone starvation induced 
mRNA production of nox1, nox2, and nox4 genes 
(Fig.  2a–c), whereas nox3 was not expressed or the 
expression level was extremely low and thus not detect-
able in FRLT5 thyroid cells. The expression analysis of 
superoxide dismutase family members, which dismutase 
O2− to H2O2, suggested decreased cytoplasmic sod1 and 
extracellular sod3 mRNA synthesis, whereas the expres-
sion of mitochondrial sod2 was increased (Fig.  2d–f). 
Interestingly, there was a significant upregulation of 
genes responsible of H2O2 removal; the expression of cat-
alase, gpx1, gpx4, gpx5, gpx6, gpx8, prdx1, prdx2, prdx3, 
prdx4, and prdx6 were all upregulated (Fig. 2g, h, j–q, s). 
Only gpx2 and prdx5 (Fig. 2i, r) did not respond to TSH 
starvation, and FRTL5 cells did not express gpx3 and 
gpx7, or their expression level was extremely low.
Effect of PTC1 and e1a oncogenes on redox gene 
expression
In cancer ROS, especially superoxide anion, mediates 
primary cell transformation and cell proliferation [5]. 
We thus analyzed the effect of PTC1 and e1a oncogene 
expression on redox gene mRNA levels in rat PC Cl3, PC 
PTC1 and PC E1A cells. As shown in Fig. 3, the mRNA 
levels of nox1-4 were upregulated by the oncogenes, 
although in PC PTC1 cells there was only a tendency 
for increased nox1 and nox4 mRNA expression. Inter-
estingly, while O2−. production was upregulated, there 
was a downregulation of genes dismutating O2−. to H2O2 
and of genes removing H2O2 from the cellular environ-
ment. The expression of sod1-3, cat, gpx1, gpx2, gpx4, 
gpx5, gpx7, and gpx8, and prdx1-6 genes was mostly 
decreased by PTC1 and e1a oncogenes thus suggesting 
redox unbalance towards increased O2− cellular concen-
tration. The expression analysis suggested reduced, or 
tendency towards reduced catalase and gpx6 expression 
in PTC1 transformed PC Cl3 cells but not clear effect in 
e1a transformed cells. Only the expression of gpx3 was 
upregulated by PTC1 and e1a oncogenes. Based on the 
data there is increased expression of nox genes forming 
NADPH complex that mainly produces O2−, whereas 
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expression of genes coding for enzymes responsible for 
removing ROS was mostly downregulated.
The effect of RAS on redox gene expression
Next we investigated the expression of redox genes 
in FRLT5 cell model that consists of cells harbor-
ing different levels of RAS: FRLT5 clone V13 has 1.4-
fold increased RAS activation, clone V21 has tenfold 
increased RAS activation, and clone V39 has 35-fold 
increased RAS activation as compared to FRLT5 con-
trol cells [2]. The expression analysis of nox gene fam-
ily suggested gradually increased nox1 mRNA synthesis 
and decreased nox2 expression correlating to increased 
RAS activation level (Fig.  4a, b), whereas nox4 expres-
sion was strongly upregulated in FRLT5 V13, FRLT5 V21, 
FRLT5 V21, and in FRLT5 V39 clones as compared to 
Fig. 1 Microarray data extracted from Oncomine database. The average expression of redox genes obtained from the database is shown as a 
histograms. a expression of nox1, b expression of nox2, c expression of nox3, d expression of nox4, e expression of nox5, f expression of sod1, g 
expression of sod2, h expression of sod3, i expression of catalase, j expression of gpx1, k expression of gpx2, l expression of gpx3, m expression of 
gpx4, n expression of gpx5, o expression of gpx7, p expression of prdx1, q expression of prdx2, r expression of prdx3, s expression of prdx4, t expres-
sion of prdx6
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control FRLT5 cells (Fig.  4c). In line with previous data 
[8], sod1 and sod2 expression varies depending on the 
cell model used. Gradually increased RAS activation 
correlated to increased sod1 mRNA levels whereas sod2 
synthesis suggested differential pattern (Fig.  4d, e). The 
expression analysis of sod3 showed increase in mRNA 
Fig. 2 The effect of TSH on redox gene expression. FRLT5 cells were treated with TSH after 3-day hormone starvation. a expression of nox1, b 
expression of nox2, c expression of nox4, d expression of sod1, e expression of sod2, f expression of sod3, g expression of catalase, h expression of 
gpx1, i expression of gpx2, j expression of gpx4, k expression of gpx5, l expression of gpx6, m expression of gpx8, n expression of prdx1, o expression 
of prdx2, p expression of gpx3, q expression of prdx4, r expression of prdx5, s expression of prdx6. The data are expressed as the mean ± SD. The p 
values are represented (*p < 0.05, **p < 0.01, ***p < 0.001)
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Fig. 3 The effect of PTC1 and e1a oncogenes on redox gene expression in PC Cl3 cell derived cancer models. a expression of nox1, b expression of 
nox2, c expression of nox3, d expression of nox4, e expression of sod1, f expression of sod2, g expression of sod3, h expression of catalase, i expres-
sion of gpx1, j expression of gpx2, k expression of gpx3, l expression of gpx4, m expression of gpx5, n expression of gpx6, o expression of gpx7, p 
expression of gpx8, q expression of prdx1, r expression of prdx2, s expression of prdx3,  t expression of prdx4, u expression of prdx5, v expression of 
prdx6. The data are expressed as the mean ± SD. The p values are represented (*p < 0.05, **p < 0.01, ***p < 0.001)
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Fig. 4 The effect of H-RasV12 oncogene on redox gene expression in FRLT5 cells derived cancer model. a expression of nox1, b expression of nox2, 
c expression of nox4, d expression of sod1, e expression of sod2, f expression of sod3, g expression of catalase, h expression of gpx1, i expression of 
gpx2, j expression of gpx3, k expression of gpx4, l expression of gpx6, m expression of gpx7, n expression of gpx8, o expression of prdx1, p expression 
of gpx2, q expression of prdx3, r expression of prdx4, s expression of prdx5,  t expression of prdx6. The data are expressed as the mean ± SD. The p 
values are represented (*p < 0.05, **p < 0.01, ***p < 0.001)
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synthesis at low RAS activation levels and significantly 
decreased sod3 mRNA production at high RAS levels 
(Fig. 4f ), as we have published recently [8]. Similarly with 
dismutase family, genes responsible of H2O2 removal 
showed variable expression. Catalase expression was 
gradually downregulated (Fig. 4g), whereas gene expres-
sion analysis of members of glutathione peroxidase fam-
ily suggested increased mRNA synthesis. Gpx1 and gpx6 
mRNA expression was upregulated in clone V21 (tenfold 
RAS activity) and in clone V13 (1.4-fold RAS activity), 
respectively (Fig. 4h, l). Other members of gpx gene fam-
ily, gpx2, gpx3, gpx4, gpx7, and gpx8 showed increased 
mRNA production corresponding to increased RAS 
activity (Fig. 4i–k, m, n). The expression of peroxiredoxin 
family members was decreased already at moderate 1.4-
fold RAS activation level excluding prdx1 and prdx6 that 
showed only a minor changes in mRNA synthesis levels 
in the cell model (Fig. 4o–t).
TPA has a time‑dependent effect on redox gene expression
The gene expression analysis of PC Cl3 cells treated with 
1.6  nM tetradecanoylphorbol acetate (TPA) on three 
consecutive days was studied to dissect the effect of gen-
eral mitogenic pressure on redox gene expression. There 
was only a modest increase in nox1 expression and a sig-
nificant long-term increase in nox4 expression (Fig.  5a, 
b). The expression of nox2 and nox3 mRNA synthesis was 
not detected suggesting that TPA treatment decreased 
their mRNA synthesis unlike PTC1 and e1a oncogenes 
(Fig. 3b, c). The expression of cytoplasmic sod1 and mito-
chondrial sod2 was significantly increased at all time 
points, whereas extracellular sod3 mRNA production 
showed modest reduction in gene expression during 
the treatment (Fig.  5c–e). Cytoplasmic catalase expres-
sion was significantly increased on all three consecutive 
days (Fig.  5f ). The overall pattern of glutathione per-
oxidase gene family mRNA synthesis suggested initially 
increased expression that returned towards the baseline 
on day three. Gpx1 expression was significantly increased 
on day 1 and on day 2, whereas on day 3 there was only 
an insignificant tendency for increased mRNA synthesis 
(Fig. 5g). The gene expressions of gpx2, gpx3, gpx4, gpx5, 
gpx6, and gpx8 were significantly increased during the 
treatment (Fig. 5h–l, n), whereas the mRNA synthesis of 
gpx7 was increased only on day 2 and returned back to 
the base line on day 3 (Fig.  5m). Prdx 1-6 gene expres-
sions were upregulated by TPA treatment on all consecu-
tive days (Fig. 5o–t).
TPA has a concentration dependent effect on redox gene 
expression
To further dissect the effect of mitogenic pressure on 
redox gene expression we treated rat thyroid PC Cl3 cells 
with 0.016, 1.6, and 16 nM TPA. We observed increased 
nox1 expression at 0.016  nM dose that was further 
strengthened at 1.6 nM concentration and returned back 
to baseline at high 16  nM TPA (Fig.  6a), whereas nox4 
expression initiated to increase at 1.6  nM concentra-
tion and suggested robust mRNA production at 16  nM 
TPA (Fig. 6b). The expression of nox2 and nox3 was not 
detectable supporting the data shown in Fig.  4. Sod1 
and sod2 mRNA expression analysis suggested signifi-
cantly increased mRNA synthesis at all TPA doses used 
(Fig.  6c, d). Sod3 expression analysis suggested signifi-
cantly increased mRNA synthesis at low 0.016 nM TPA 
concentration, baseline expression at 1.6  nM TPA, and 
significantly decreased expression at high 16  nM TPA 
(Fig.  6e). Catalase expression was at similar levels with 
control cells at 0.016 nM and at 1.6 nM TPA doses, and 
decreased at 16 nM TPA (Fig. 6f ). The expression anal-
ysis of glutathione peroxidases family members gpx1, 
gpx2, gpx3, gpx4, gpx5, gpx6, gpx7, and gpx8 suggested 
increased mRNA synthesis correlating to increased TPA 
concentration (Fig.  6g–n). The expression analysis of 
peroxiredoxins suggested increased mRNA synthesis of 
prdx1 at all TPA doses (Fig. 5o), of prdx3 at 1.6 nM and 
at 16 nM TPA concentrations (Fig. 6q), and of prdx4 at 
16  nM TPA (Fig.  6r). The expressions of prdx2, prdx5, 
and prdx6 were unaffected at all TPA concentrations 
(Fig. 6p, s, t).
SOD3 enhances the TPA derived increased cell proliferation 
and loss of normal cellular phenotype
Based on the current data sod3 gene expression showed 
RAS activation-dependent and TPA concentration-
dependent initial increase that was then decreased 
at high RAS activation and TPA concentration levels 
(Figs. 4f, 6e). Thus, we studied the effect of SOD3 over-
expression on the growth of PC Cl3 cells during TPA 
treatment. BrdU DNA incorporation and cell count 
analysis suggested that SOD3 over-expression signifi-
cantly enhanced TPA stimulated DNA proliferation and 
cell growth as compared to control cells (Fig. 7a, b). PC 
Cl3 cells characteristically grow in follicular clusters in 
the growth medium supplemented with thyroid hor-
mones and growth factors. TPA treatment had a concen-
tration and a time-dependent effect on control PC Cl3 
cells causing the loss of the characteristic follicular clus-
ter conformation phenotype (Fig. 7a–h). At 1.6 nM TPA 
concentration (Fig. 7a–c) the loss of the follicular growth 
formation was slower than at high 16 nM TPA concen-
tration (Fig.  7f–h) that disrupted the normal growth 
phenotype already at 12-h time point after the initiation 
of TPA supplementation. PC Cl3 cells over-expressing 
human SOD3 showed earlier loss of the follicular cluster 
conformation phenotype that initiated at 12-h time point 
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Fig. 5 Dose-dependent effect of TPA on redox gene expression in PC Cl3 cells. a expression of nox1, b expression of nox4, c expression of sod1, d 
expression of sod2, e expression of sod3, f expression of catalase, g expression of gpx1, h expression of gpx2, i expression of gpx3, j expression of 
gpx4, k expression of gpx5, l expression of gpx6, m expression of gpx7, n expression of gpx8, o expression of prdx1, p expression of gpx2, q expression 
of prdx3, r expression of prdx4, s expression of prdx5,  t expression of prdx6. The data are expressed as the mean ± SD. The p values are represented 
(*p < 0.05, **p < 0.01, ***p < 0.001)
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and suggested spindle like phenotype at 24-h time point 
(Fig. 7i–k).
Discussion
Primary cell transformation and malignant cancer 
development is frequently characterized by increased 
oxidative stress that induces mutations and increases 
growth signaling. The data extracted from Oncomine 
database suggested increased NOX1-5 gene expres-
sion that, as part of NADPH oxidase complex, induces 
O2− production (Fig. 1). In line with previously published 
reports, Oncomine data showed reduced expression of 
genes coding for enzymes that remove oxygen radicals 
from the tissue environment. The only exceptions were 
increased expression of mitochondrial SOD2, GPX1, and 
GPX2 [9–11] thus highlighting the importance of mito-
chondrial activity in tumorigenesis [12].
Thyroid stimulating hormone is an important media-
tor of normal thyroid physiology whereas transformed 
thyroid cells develop the ability to grow independently 
Fig. 6 Time-dependent effect of TPA on redox gene expression in PC Cl3 cells. a expression of nox1, b expression of nox4, c expression of sod1, d 
expression of sod2, e expression of sod3, f expression of catalase, g expression of gpx1, h expression of gpx2, i expression of gpx3, j expression of 
gpx4, k expression of gpx5, l expression of gpx6, m expression of gpx7, n expression of gpx8, o expression of prdx1, p expression of gpx2, q expression 
of prdx3, r expression of prdx4, s expression of prdx5,  t expression of prdx6. The data are expressed as the mean ± SD. The p values are represented 
(*p < 0.05, **p < 0.01, ***p < 0.001)
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of hormone stimulation [13]. Several thyroid patholo-
gies are characterized by abnormal TSH production 
thus compromising hormone related signal transduction 
and thyroid function. TSH acts through TSH receptor, 
a member of small G-protein coupled receptor family, 
regulating thyroid hormone T3 and T4 production, thy-
roid growth, and cell differentiation through adenylyl 
cyclase and cAMP signaling pathways [14]. TSH con-
centration is markedly increased in Hashimoto’s disease, 
which is also characterized by increased oxidative stress 
Fig. 7 The effect of SOD3 over-expression on TPA treated PC Cl3 cells. a BrdU incorporation analysis suggested SOD3-enhanced DNA replication. b 
Growth curve analysis supported BrdU assay suggesting increased growth in the presence of SOD3. c–e The effect of 1.6 nM TPA on PC Cl3 cell fol-
licular growth formation. f–h The effect 16 nM TPA on PC Cl3 cell follicular growth formation. i–k The combined effect of 16 nM TPA and SOD3 over-
expression on PC Cl3 cell follicular growth formation. The data are expressed as the mean ± SD. The p values are represented (*p < 0.05, **p < 0.01, 
***p < 0.001)
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[15], whereas Graves’s disease is characterized by low 
levels of TSH in compensation of high T3 and T4 hor-
mone concentrations in circulation. Grave’s disease is an 
autoimmune disease associated with increased oxida-
tive stress, mainly originating from migrating inflamma-
tory cells [16]. The current data showed TSH-stimulated 
signal transduction regulating redox gene expression in 
FRLT5 cells (Fig. 2) suggesting feasibility of the cells for 
Hashimoto’s disease and Grave’s disease related oxida-
tive stress studies. In support of the current data, we have 
previously shown in line with the current work that TSH 
stimulation decreases sod3 expression in PC Cl3 cells [6].
Thyroid cancers arise from epithelial cell mutations, 
such as RET/PTC genetic aberration formed by chromo-
somal rearrangement of RET tyrosine kinase domain to 
N-terminal of H4 (D10S170) [17] and frequently associ-
ated to radiation derived papillary thyroid cancer [18]. A 
number of cell lines expressing oncogenes, e.g. adenovi-
rus adenovirus Ad12 early region 1A (e1a), are used to 
study the development and characteristics of thyroid can-
cer. The oncogenic nature of e1a has been linked to virus 
dose, host genetic constitution, age of the host at the time 
of infection, and immune status of the host. The viral 
e1a sequence drives primary cells towards transforma-
tion by affecting signal transduction pathways involved in 
immune escape, p53 response, and protein stability [19]. 
Rat thyroid PC Cl3 cells transfected with e1a lack the dif-
ferentiation ability and show characteristics of TSH inde-
pendent growth and function [20]. The frequency of ras 
mutations in thyroid tumors vary from 0  % up to 85  % 
showing increased occurrence in poorly differentiated 
and undifferentiated thyroid cancers [21, 22]. The aber-
rant activation of RAS-BRAF-MEK1/2-ERK1/2 kinase 
signaling pathway, which mediates the extracellular sig-
nals into the nucleus, contributes to thyroid carcinoma 
by increasing cell proliferation, survival, and metastasis.
In the current work redox gene expression PC Cl3 
cells transformed with PTC1 and e1a oncogenes sug-
gested partial similarity between human microarray 
data and cell models. The expression of nox2, nox3, and 
nox4 in cell models showed similar increase as in thy-
roid cancers tissues whereas the decreased expression 
of sod3, catalase, gpx5, gpx7, prdx1, prdx2, and prdx3 
corresponded to decreased expression in microarray 
data. It is important to note that the expression of nox1, 
sod1, sod2, gpx1, gpx3, gpx4, gpx8, prdx4, and prdx6 in 
cell models was opposite to human tissues. Further, 
gpx6 and prdx5 that showed variable expressions in cell 
models were not expressed in human cancers (Fig.  3). 
Thus, out of 22 redox genes 10 showed similar expres-
sion pattern in thyroid tissues and PTC1 or e1a derived 
cell models. In FRLT5 based H-RasV12 cell model the 
expression of nox4, sod2, sod3, catalase, gpx2, gpx4, and 
prdx6 corresponded to human tissue mRNA production. 
The expression of gpx1 was variable and the expression 
of nox1, nox2, sod1, gpx3, gpx7, prdx1, prdx2, prdx3, and 
prdx4 in cell model was opposite to expression in thyroid 
tissue. In line with PTC1 and e1a models, gpx6, gpx8, 
and prdx5, which were absent in human microarray data, 
showed mRNA production in FRLT5 cell model indicat-
ing that seven redox genes out of 22 had similar expres-
sion pattern in cells and tissues (Fig. 4).
The differences between tissue microarray database 
and in  vitro gene expression assays may be caused by 
presence of stromal paracrine effect influencing tissue 
redox balance or presence of multiple genetic aberrations 
in  vivo. In human tissues increased expression of NOX 
genes is mainly caused by small RAS GTPase protein 
activation [23–25] or cytokines stimulus [26–28], thus 
suggesting direct involvement of ras family genes in nox 
mRNA production in FRLT5 clones V13, V21, and V39 
(Fig.  4). Similarly with NOX genes ras oncogene signal-
ing has been suggested to be involved in SOD1, SOD2, 
and SOD3 gene expression through PI3K-AKT [29, 30] 
and RAS-RAF-MEK-ERK pathways [31] CATALASE 
mRNA expression, which was decreased in  vitro mod-
els by oncogenes, is stimulated by PI3K-AKT and AMPK 
signaling [32, 33], whereas glutathione peroxidase fam-
ily gene expression, another H2O2 metabolizing enzyme 
group, is activated by proto-oncogenes, such as ets-1 [34], 
by antioxidative Keap1 signaling [35], by peroxisome 
proliferator-activated receptor γ signaling [36], by ROS 
[37], and by cytokines [35]. The third H2O2 metabolizing 
enzyme group, peroxiredoxin gene family, is activated by 
immune response inducing proteins, such as lipopolysac-
charide through ROS-p38 MAPK [38, 39] by proto-onco-
gene SRC-PI3 K-JNK pathway [40], by PI3K-AKT [41], by 
cytokines [42, 43] and by various kinds of antioxidative 
molecules [35, 44].
TPA is a tumor promoter that induces high ROS, 
especially O2−, production [28] and therefore it is often 
used to characterize the effect of superoxide dismutases 
in vitro [45] and in vivo models [46]. In the current study 
TPA administration time-dependently increased redox 
gene expressions (Fig.  5) but dose-dependently showed 
differential response in redox gene expression (Fig.  6). 
Because sod3 mRNA dose-dependent response to TPA 
(Fig. 6e) suggested similar expression pattern as observed 
in FRLT5 H-RasV12 clones V13, V21, and V39 (Fig. 4f ), 
we characterized in more detail the effect of sod3 over-
expression in TPA treated PC Cl3 cells (Fig. 7). Our pre-
vious observations have suggested a coordinated action 
of SOD3 and RAS small GPTase signal transduction thus 
indicating that SOD3 supports growth by increasing 
RAS-ERK1/2 and PI3  K-AKT signal transduction path-
way activation [8, 31, 47, 48]. The current data suggesting 
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increased cell proliferation in TPA treated cells in the 
presence of SOD3 as compared to control cells (Fig.  7) 
supports previous observations suggesting that SOD3 
may be a growth promoter contributing to cell prolifera-
tion at early phase of tumorigenesis.
Conclusions
As a conclusion, according to our data PC Cl3, PC PTC1, 
PC E1A cell model systems corresponded to human 
NOX2, NOX4, SOD3, CATALASE, GPX5, and GPX7 gene 
expressions in thyroid cancer. Used FRLT5 clones V13, 
V21, and V39 modeled human NOX2, NOX4, SOD2, 
SOD3, CATALASE, GPX1, GPX2, PRDX2, and PRDX3 
gene expressions. TPA administration to rat thyroid 
PC Cl3 cells could be used to study the effect of NOX2, 




Rat thyroid PC Cl3, PC PTC1, PC E1A, FRLT5, and 
FRTL5-related cell clones V13, V21, and V39 stably 
transfected with H-RasV12 expression plasmid [2] were 
cultured in Ham’s F12 medium Coon’s modified (Sigma, 
St Louis, MO, USA) supplemented with 5  % calf serum 
(Life Technologies, Inc., Carlsbad, CA, USA), penicil-
lin (100 U/mL) (Sigma), and streptomycin (100  mg/L) 
(Sigma). PC Cl3 and FRLT5 cells (modeling normal thy-
roid cells) were additionally supplemented with 10  nM 
thyroid stimulating hormone (TSH), 10  nM hydrocorti-
sone, 100 nM insulin, 5 mg/mL transferrin, 5 nM soma-
tostatin, and 20 mg/mL glycyl-histidyl-lysine.
Treatment of cells
To study effect of TSH on redox gene expression, FRLT5 
cells were cultured 3 days without hormone supplemen-
tation, stimulated for 6 h with 10 nM TSH, and collected 
for RNA isolation. To study dose-dependent effect of 
tetradecanoylphorbol acetate (TPA) (Sigma) on redox 
gene expression and cellular growth, PC Cl3 cells were 
treated with 0.016, 1.6 or 16  nM TPA for 8  h and pel-
leted for RNA isolation. To study time-dependent effect 
of TPA on redox gene expression, PC Cl3 cells were sup-
plemented with fresh medium containing 1.6  nM TPA 
at day 0, day 1, and day 2. Cells were collected on day 
1, day 2, and day 3 for RNA isolation. To study effect of 
TPA on cell growth, PC Cl3 control cells and PC Cl3 cells 
over-exressing SOD3 (kindly provided by professor Ste-
fan L. Marklund from the University of Umeå, Sweden) 
were treated with 1.6 and 16 nM TPA and prepared for 
BrdU DNA replication analysis, growth curve analy-
sis, and microscopy. SOD3 over-expressing and control 
plasmid PC Cl3 cells were prepared by transfecting cells 
with Fugene 6 (Roche, Mannheim, Germany) followed 
by geneticin antibiotic (Sigma) selection to create stable 
cells lines.
Real time PCR for mRNA expression analysis
For mRNA expression total RNA was extracted using 
an RNeasy mini kit (Qiagen, Hilden, Germany). RNA (1 
μg) was reverse transcribed with Quantitect Reverse® 
Transcription Kit (Qiagen). Primers were designed 
with (http://www-genome.wi.mit.edu/cgi-bin/primer/
primer3_www.cgi). cDNA was done by GeneAmp RNA 
PCR Core Kit system (Qiagen). Reactions were per-
formed in triplicate using SYBR Green PCR Master mix 
(Applied Biosystems, Foster City, CA, USA) and iCycler 
(BioRad, Hercules, CA, USA). Fluorescent threshold val-
ues were calculated using formula 2−(sample 1 ΔCt −  sample 2 
ΔCt), where ΔCt is difference between amplification fluo-
rescent threshold (Ct) of mRNA of interest, and Ct of 
ß-actin mRNA used as housekeeping gene. Primers are 
listed in Additional file 1: Table S1.
Growth analysis
For BrdU DNA replication analysis PC Cl3 cell cultures 
grown on coverslips were supplemented with 10  mM 
bromodeoxyuridine (BrdU; Roche, Basel, Switzerland) 
for 15  min. Subsequently, cells were fixed in 3  % para-
formaldehyde (Sigma) and permeabilized with 0.2  % 
Triton X-100 (Sigma). The coverslips were incubated 
with anti-BrdU antibody followed by FITC–conjugated 
secondary antibody (Jackson ImmunoResearch Labora-
tories Inc., West Grove, PA, USA). Nuclei were counter-
stained with HOECST (Sigma). For growth curve analysis 
PC Cl3 cells were grown in 6-well dishes. The number of 
cells was counted in triplicate from control and SOD3 
wells in each analysis date by burker chamber using 
formula: number of cells/ml  =  average of cells in each 
square × 104 × dilution factor.
Statistical analyses
The experiments were repeated at least three times. All 
results are expressed as the mean  ±  SD. The p values 
(*p < 0.05, **p < 0.01, ***p < 0.001) were determined by 
two-tailed independent samples t test.
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